217 related articles for article (PubMed ID: 23729438)
1. CD166/ALCAM mediates proinflammatory effects of S100B in delayed type hypersensitivity.
von Bauer R; Oikonomou D; Sulaj A; Mohammed S; Hotz-Wagenblatt A; Gröne HJ; Arnold B; Falk C; Luethje D; Erhardt A; Stern DM; Bierhaus A; Nawroth PP
J Immunol; 2013 Jul; 191(1):369-77. PubMed ID: 23729438
[TBL] [Abstract][Full Text] [Related]
2. S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release.
Bianchi R; Kastrisianaki E; Giambanco I; Donato R
J Biol Chem; 2011 Mar; 286(9):7214-26. PubMed ID: 21209080
[TBL] [Abstract][Full Text] [Related]
3. Activated leucocyte cell adhesion molecule (ALCAM/CD166) regulates T cell responses in a murine model of food allergy.
Kim YS; Kim MN; Lee KE; Hong JY; Oh MS; Kim SY; Kim KW; Sohn MH
Clin Exp Immunol; 2018 May; 192(2):151-164. PubMed ID: 29363753
[TBL] [Abstract][Full Text] [Related]
4. S100B attenuates microglia activation in gliomas: possible role of STAT3 pathway.
Zhang L; Liu W; Alizadeh D; Zhao D; Farrukh O; Lin J; Badie SA; Badie B
Glia; 2011 Mar; 59(3):486-98. PubMed ID: 21264954
[TBL] [Abstract][Full Text] [Related]
5. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells.
Reddy MA; Li SL; Sahar S; Kim YS; Xu ZG; Lanting L; Natarajan R
J Biol Chem; 2006 May; 281(19):13685-13693. PubMed ID: 16551628
[TBL] [Abstract][Full Text] [Related]
6. Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function.
Ikeda K; Quertermous T
J Biol Chem; 2004 Dec; 279(53):55315-23. PubMed ID: 15496415
[TBL] [Abstract][Full Text] [Related]
7. Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis.
Loeser RF; Yammani RR; Carlson CS; Chen H; Cole A; Im HJ; Bursch LS; Yan SD
Arthritis Rheum; 2005 Aug; 52(8):2376-85. PubMed ID: 16052547
[TBL] [Abstract][Full Text] [Related]
8. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
9. S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain.
Adami C; Bianchi R; Pula G; Donato R
Biochim Biophys Acta; 2004 Dec; 1742(1-3):169-77. PubMed ID: 15590067
[TBL] [Abstract][Full Text] [Related]
10. Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: involvement of Toll-like receptor 2.
Monden M; Koyama H; Otsuka Y; Morioka T; Mori K; Shoji T; Mima Y; Motoyama K; Fukumoto S; Shioi A; Emoto M; Yamamoto Y; Yamamoto H; Nishizawa Y; Kurajoh M; Yamamoto T; Inaba M
Diabetes; 2013 Feb; 62(2):478-89. PubMed ID: 23011593
[TBL] [Abstract][Full Text] [Related]
11. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.
Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Rauvala H
J Biol Chem; 2000 Dec; 275(51):40096-105. PubMed ID: 11007787
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products.
Shanmugam N; Kim YS; Lanting L; Natarajan R
J Biol Chem; 2003 Sep; 278(37):34834-44. PubMed ID: 12837757
[TBL] [Abstract][Full Text] [Related]
13. S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner.
Sorci G; Riuzzi F; Agneletti AL; Marchetti C; Donato R
Mol Cell Biol; 2003 Jul; 23(14):4870-81. PubMed ID: 12832473
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of receptor for advanced glycation end products induces monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cell line.
Hayakawa E; Yoshimoto T; Sekizawa N; Sugiyama T; Hirata Y
J Atheroscler Thromb; 2012; 19(1):13-22. PubMed ID: 22082983
[TBL] [Abstract][Full Text] [Related]
15. Neural-activity-dependent release of S100B from astrocytes enhances kainate-induced gamma oscillations in vivo.
Sakatani S; Seto-Ohshima A; Shinohara Y; Yamamoto Y; Yamamoto H; Itohara S; Hirase H
J Neurosci; 2008 Oct; 28(43):10928-36. PubMed ID: 18945900
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes.
Figarola JL; Shanmugam N; Natarajan R; Rahbar S
Diabetes; 2007 Mar; 56(3):647-55. PubMed ID: 17327432
[TBL] [Abstract][Full Text] [Related]
17. ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy.
Sulaj A; Kopf S; Gröne E; Gröne HJ; Hoffmann S; Schleicher E; Häring HU; Schwenger V; Herzig S; Fleming T; Nawroth PP; von Bauer R
J Diabetes Complications; 2017 Jun; 31(6):1058-1065. PubMed ID: 28325697
[TBL] [Abstract][Full Text] [Related]
18. Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.
Bowen MA; Bajorath J; D'Egidio M; Whitney GS; Palmer D; Kobarg J; Starling GC; Siadak AW; Aruffo A
Eur J Immunol; 1997 Jun; 27(6):1469-78. PubMed ID: 9209500
[TBL] [Abstract][Full Text] [Related]
19. RAGE ligand upregulation of VEGF secretion in ARPE-19 cells.
Ma W; Lee SE; Guo J; Qu W; Hudson BI; Schmidt AM; Barile GR
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1355-61. PubMed ID: 17325184
[TBL] [Abstract][Full Text] [Related]
20. RAGE regulates immune cell infiltration and angiogenesis in choroidal neovascularization.
Chen M; Glenn JV; Dasari S; McVicar C; Ward M; Colhoun L; Quinn M; Bierhaus A; Xu H; Stitt AW
PLoS One; 2014; 9(2):e89548. PubMed ID: 24586862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
